BioSpace News Archive

UCB, a global biopharmaceutical company, today announced positive top-line results from the Phase 3 BE COMPLETE study, which evaluated the efficacy and safety of bimekizumab in the treatment of adults with active psoriatic arthritis, who were inadequate responders or intolerant to anti-tumor necrosis factor-alpha (anti-TNF-α) therapy.

Transcat, Inc. announced that it will release its third quarter fiscal year 2022 results after the close of financial markets on Tuesday, February 1, 2022.

The rapid spread of COVID-19, a disease caused by the SARS-CoV-2 virus, has created a public health crisis around the world.

Medivir AB (Nasdaq Stockholm: MVIR-B) today announces that an e-poster entitled “Liver biopsy biomarkers in a phase 1 study of the prodrug MIV-818 demonstrates proof-of-concept for cancer in the liver” will be presented at the European Association for the Study of the Liver (EASL) Liver Cancer Summit 3-4 February.

The Global Proteolytic Enzymes Market Research Report, published by Reports and Data, is a detailed account of the global Proteolytic Enzymes market and its key segments.